BD Unveils AI-Based Hemodynamic Monitoring Platform for Clinical Decision Support

The system integrates AI-based predictive algorithms, including the Acumen Hypotension Prediction Index (HPI), which anticipates hypotensive episodes.

BD (Becton, Dickinson, and Company) has launched HemoSphere Alta, an advanced hemodynamic monitoring platform designed to help clinicians manage blood pressure fluctuations during medical procedures.

The platform is the first significant release from BD’s Advanced Patient Monitoring division following its recent acquisition.

AI-Powered Hypotension Prediction and Brain Flow Monitoring

The system integrates AI-based predictive algorithms, including the Acumen Hypotension Prediction Index (HPI), which anticipates hypotensive episodes. In several multicenter clinical trials, the HPI software has been shown to reduce the depth and duration of low blood pressure.

A key feature of the new platform is the Cerebral Autoregulation Index (CAI), designed to help clinicians assess whether the brain can maintain stable blood flow amid systemic blood pressure changes. This feature becomes functional when using both the noninvasive ForeSight IQ Sensor, placed on the patient’s forehead, and the Acumen IQ Sensor connected to the arterial line.

“Research over the past two decades has demonstrated the wide variability of the lower limit of cerebral blood flow autoregulation between individuals,” said Dr. Charles Hogue, Chairman of the Department of Anesthesiology, Northwestern University Feinberg School of Medicine.

“The Cerebral Autoregulation Index provides a tool to detect impaired autoregulation and identify individual patient thresholds. It enables more personalized blood pressure management with HPI and other software on HemoSphere Alta.”

Enhanced Clinical Workflow and Hands-Free Operation

Beyond clinical insight, the HemoSphere Alta system includes usability upgrades to improve in-procedure workflows. These include a 15-inch high-resolution touchscreen, customizable screen layouts, and split-screen functionality. The device also supports voice and gesture commands, allowing hands-free interaction to preserve sterility in surgical settings.

“HemoSphere Alta redefines the clinician experience with more efficient workflows and enhanced usability,” said Tim Patz, President of BD Advanced Patient Monitoring. “AI-driven algorithms provide greater clinical decision support to help improve care quality.”

BD continues to expand its footprint in connected care technologies with the HemoSphere Alta system, advancing its focus on AI-powered decision support tools in patient monitoring.